Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply
Resilience and Lilly expand strategic partnership first established in 2023 Investment will significantly increase U.S. production of Lilly’s...
BLOG
Read on
Resilience Announces Relocation of West Coast Headquarters to Ohio and Expansion of Sterile Manufacturing Capabilities
BLUE ASH, Ohio, June 18, 2026 – Resilience, along with Ohio Governor Mike DeWine, JobsOhio, the City of Blue Ash, and REDI Cincinnati, today...
How integrated data systems enhance clinical development and manufacturing
Published by PharmaVoice In the rapidly evolving landscape of biopharmaceuticals, the integration of robust digital systems has become paramount....
Meet the Team: Viral Vector Development & Manufacturing
Meet Kyle Anderson, Ph.D., Director of Manufacturing Science and Technology (MSAT) at Resilience RTP, North Carolina & Xiaotong Fu, Ph.D., Head of...
Building Velocity into Fill/Finish Timelines: Your Guide to Quality and Regulatory Success in the CDMO Space
Manufacturing capabilities need innovation proportional to those in therapeutics discovery. Choosing a CDMO partner with the technologies and...
On-Demand Webinar: Outsourced Pharma Capacity Update 2024 - Large Molecules
Are you an innovative company looking for a dependable CDMO partner for your large molecule projects? You have come to the right place.
The Stage-Gate Model: A Proven Approach to Streamline Biomanufacturing
As biopharma companies outsource more specialized activity to CDMOs, successful technology transfer becomes even more integral to project success. To...
On Demand Webinar: Outsourced Pharma Capacity Update-Large Molecules
Are you an innovator company looking for a reliable and innovative partner? You have come to the right place.
